BERMEKİMAB İLE DENEYSEL SİSTEMİK SKLEROZ TEDAVİSİNİN İLK FAZI BAŞLIYOR - 2019.10.18
Bermekimab (deneysel bir monoklonal antikor) ile deneysel sistemik skleroz tedavisinin ilk fazı başlıyor...
#Skleroderma #SistemikSkleroz #Repost @scleroderma_txchapter (@get_repost)
・・・
Phase 1 Study of Experimental Systemic Sclerosis Treatment Bermekimab Begins bit.ly/32pFA8G #raredisease #SystemicSclerosis #SystemicScleroderma #SSc #Scleroderma @scleroderma #findacure #curescleroderma #sclerodermaresearch
HABERLER
